A mechanism for selective induction of 2'-5' oligoadenylate synthetase, anti-viral state, but not MHC Class I genes by interferon-beta in neurons

Journal of NeuroVirology

Volumn 5, Issue 2, 1999, Pages 161-171

  Massa, Paul T ^a,c   Whitney, Laurie W ^a,b   Wu, Charlene ^a   Ropka, Stacie L ^a   Jarosinski, Keith W ^a  

^a SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

Central nervous system infections; Enhancer elements; Gene expression regulation; Signal transduction; Transcription factors; Virus replication

Indexed keywords

BETA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; SYNTHETASE; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; ASTROCYTE; CENTRAL NERVOUS SYSTEM INFECTION; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE INDUCTION; MOUSE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; SOMATIC CELL; VIRUS INFECTION; VIRUS REPLICATION;

ANIMALIA;

EID: 0032919791     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.3109/13550289909021998     Document Type: Article

References (73)

1. Bandyopadhyay SK, Leonard Jr, GT, Bandyopadhyay T, Stark GR, Sen GC (1995). Transcriptional induction by double-stranded RNA is mediated by interferon-stimulated response elements without activation of interferon-stimulated gene factor 3. J Biol Chem 270: 19624-19629.
2. Benech P, Mory Y, Revel M, Chebeth J (1985). Structure of two forms of the interferon-induced (2′-5′) oligo A synthetase based on cDNAs and gene sequences. EMBO J 4: 2249-2256.
3. Benech P, Vigneron M, Peretz D, Revel M, Chebath J (1987). Interferon-responsive regulatory elements in the promoter of the human 2′, 5′-oligo(A) synthetase gene. Mol Cell Biol 7: 4498-4504.
4. γ, p48, a specificity switch for interferon activated transcription factors. Cytokine and Growth Factor Reviews 7: 11-17.
5. Chang CH, Hammer J, Loh JE, Fodor WL, Flavell RA (1992). The activation of major histocompatibility complex class I genes by interferon regulatory factor-1 (IRF-1). Immunogenetics 35: 378-384.
6. Chomczynski P and Sacci N (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159.
7. Coccia EM, Romeo G, Nissim A, Marziali G, Albertini R, Affabris E, Battistini A, Fiorucci G, Orsatti R, Rossi GB, Chebath J (1990). A full-length murine 2-5A synthetase cDNA transfected in NIH-3T3 cells impairs EMCV but not VSV replication. Virol 179: 228-233.
8. Coccia EM, Marziali G, Stellacci E, Perrotti E, Ilari R, Orsatti R (1995). Cells resistant to interferon-beta respond to interferon-gamma via the Statl-IRF-1 pathway. Virol 211: 113-122.
9. Cohen B, Peretz D, Vaiman K, Benech P, Chebath J (1988). Enhancer-like interferon responsive sequences of the human and murine (2′-5′) oligoadenylate synthetase gene promoters. EMBO J 7: 1411-1419.
10. Decker T, Kovarik P, Meinke A (1997). GAS elements: a few nucleotides with a major impact on cytokine-induced gene expression. J Interferon and Cytokine Res 17: 121-134.
11. Drew PD, Lonergan M, Goldstein ME, Lampson LA, Ozato K, McFarlin DE (1993). Regulation of MHC class I and β2-microglobulin gene expression in human neuronal cells. J Immunol 150: 3300-3310.
12. Drew PD, Franzoso G, Becker KG, Bours V, Carlson LM, Siebenlist U, Ozato K (1995a). NFκ-B and interferon regulatory factor 1 physically interact and synergistically induce major histocompatability class I gene expression. J Interferon and Cytokine Res 15: 1037-1045.
13. Drew PD, Franzoso G, Carlson LM, Biddison WE, Siebenlist U, Ozato K (1995b). Interferon regulatory factor-2 physically interacts with NF-kappa B in vitro and inhibits NF-kappa B induction of major histocaompatability class I and beta 2-microglobulin gene expression in transfected human neuroblastoma cells. J Neuroimmunol 63: 157-162.
14. Durbin JE, Hackenmiller R, Simon MC, Levy DE (1996). Targeted disruption of the mouse Statl gene results in compromised innate immunity to viral disease. Cell 84: 443-450.
15. Fan C-M, Maniatis T (1989). Two different virus-inducible elements are required for human β-Interferon gene regulation. EMBO J 8: 101-110.
16. Fiette L, Aubert C, Muller U, Huang S, Aguet M, Brahic M, Bureau J-F (1995). Theiler's virus infection of 129Sv mice that lack the interferon α/β or interferon γ receptors. J Exp Med 181: 2069-2076.
17. Fried M, Crothers DM (1981). Equilibria and kinetics of lac repressor-operator interactions by polyacrylamide gel electrophoresis. Nucleic Acids Res 9: 6505-6525.
18. Fu X-Y, Schindler C, Improta T, Aebersold R, Darness Jr, JE (1992). The proteins of ISGF-3, the Interferon α-induced transcriptional activator, define a gene family involved in signal transduction. Proc Natl Acad Sci USA 89: 7840-7843.
19. Garner M, Rezvin A (1981). A gel electrophoresis method for quantifying the binding of proteins to specific DNA regions: applications to components of the E. coli lactose operon regulatory system. Nucleic Acids Res 9: 3047-3060.
20. Ghosh SK, Kusari J, Bandyopadhyay SK, Samanta H, Kumar R, Sen GC (1991). Cloning, sequencing, and expression of two murine 2′-5′-oligoadenylate synthetases. Structure-function relationships. J Biol Chem 266: 15293-15299.
21. Gorman C, Moffat E, Howard B (1982). Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol Cell Biol 2: 1044-1051.
22. Gribaudo G, Lembo D, Cavallo G, Landolfo S, Lengyel P (1991). Interferon action: binding of viral RNA to the 40-kilodalton 2′-5′-oligoadenylate synthetase in interferon-treated HeLa cells infected with encephalomyocarditis virus. J Virol 65: 1748-1757.
23. Harada H, Fukita T, Miyamoto M, Kimura Y, Maruyama M, Furia A, Miyata T, Taniguchi T (1989). Structurally similar but functionally distinct factors, IRF-1 and IRF-2, bind to the same regulatory elements of IFN and IFN-inducible genes. Cell 58: 729-739.
24. Harada H, Willison K, Sakakibara J, Miayamoto M, Taniguchi T (1990). Absence of the type I IFN system in EC cells: Transcriptional activator (IRF-1) and repressor (IRF-2) genes are developmentally regulated. Cell 63: 303-312.
25. Harada H, Takahashi E, Itoh S, Harada K, Hori TA, Taniguchi T (1994). Structure and regulation of the human interferon regulatory factor 1 (IRF-1) and IRF-2 genes: implications for a gene network in the interferon system. Mol Cell Biol 14: 1500-1509.
26. Hobart M, Ramassar V, Goes N, Urmson J, Halloran PH (1997). IFN regulatory factor-1 plays a central role in the regulation of the expression of class I and II MHC genes in vivo. J Immunol 158: 4260-4269.
27. Horvath CM, Darnell Jr, JE (1996). The antiviral state induced by alpha interferon and gamma interferon requires transcriptionally active Statl protein. J Virol 70: 647-650.
28. Hovanessian AG (1991). Interferon-induced and double-stranded RNA-activated enzymes: a specific protein kinase and 2′, 5′-oligoadenylate synthetases. J Interferon Res 11: 199-205.
29. Ichji Y, Fukunaga R, Shiojiri S, Sokawa Y (1986). Mouse 2-5A synthetase cDNA: nucleotide sequence and comparison to human 2-5A synthetase. Nucle'c Acids Res 14: 10117.
30. Ihle JN (1996). STATS: Signal transducers and activators of transcription. Cell 84: 331-334.
31. Israel A, Le Bail O, Hatat D, Piette J, Kieran M, Logeat F, Wallach D, Fellous M, Kourilsky P (1989). TNF stimulates expression of mouse MHC class I genes by inducing an NF kappa B-like enhancer binding activity which displaces constitutive factors. EMBO J 8: 3793-3800.
32. Joly E, Mucke L, Oldstone MBA (1991). Viral persistence in neurons explained by lack of major histocompatibility class I expression. Science 253: 1283-1285.
33. Joly E, Oldstone MB (1992). Neuronal cells are deficient in loading peptides onto MHC class I molecules. Neuron 8: 1185-1190.
34. Khabar KSA, Al-Zoghaibi F, Dzimiri M, Taha M, Al-Tuwaijri A, Al-Ahda N (1996). MTS interferon assay: A simplified cellular dehydrogenase assay for interferon activity using a water-soluble tetrazolium salt. J Interferon and Cytokine Res 16: 31-33.
35. Korber B, Mermod N, Hood L, Stroynowski I (1988). Regulation of gene expression by interferons: control of H-2 promoter responses. Science 239: 1301-1306.
36. Kumar A, Yang Y-L, Flati V, Der S, Kadereit S, Deb A, Haque J, Reis L, Weissman C, Williams BRG (1997). Deficient cytokine signaling in mouse embryo fibroblasts with a targeted deletion in the PKR gene: role of IRG-1 and NF-κB. EMBO J 16: 406-416.
37. Kumar R, Choubey D, Longyel P, Sen GC (1988). Studies on the role of the 2′-5′-oligoadenylate synthetase-RNase L pathway in beta interferon-medaited inhibiton of oncephalomyocarditis virus replication. J Virol 62: 3175-3181.
38. Landolfo S, Gribaudo G, Angeretti A, Gariglio M (1995). Mechanisms of viral inhibition by interferons. Pharmac Ther 65: 415-442.
39. Lee KA, Bindereif A, Green MR (1988). A small-scale procedure for preparation of nuclear extracts that support efficient transcription and pre-mRNA splicing. Gene Anal Tech 5: 22-31.
40. Lenardo MJ, Fan C-M, Maniatis T, Baltimore D (1989). The involvement of NF-κB in β-Interferon gene regulation reveals its role as widely inducible mediator of signal transduction. Cell 57: 287-294.
41. Levine B, Hardwick JM, Trapp BD, Crawford TO, Bollinger RC, Griffin DE (1991). Antibody-mediated clearance of alphavirus infection from neurons. Science 254: 856-860.
42. Levine B, Goldman JE, Jiang HH, Griffin DE, Hardwick JM (1996). BCL-2 protects mice against fatal alpha-virus encephalitis. Proc Natl Acad Sci USA 93: 4810-4815.
43. Levy DE, Kessler DS, Pine R, Reich N, Darnell Jr, JE (1988). Interferon-induced nuclear factors that bind a shared promoter element correlate with psoitive and negative transcriptional control. Genes & Development 2: 383-393.
44. Lew DJ, Decker T, Strehlow I, Darnell JE (1991). Overlapping elements in the guanylate-binding protein gene promoter mediate transcriptional induction by alpha and gamma interferons. Mol Cell Biol 11: 182-191.
45. Massa PT, Hirschfeld S, Levi B-Z, Quigley LA, Ozato K, McFarlin DE (1992). Expression of major histocompatibility complex (MHC) class I genes in astrocytes correlates with the presence of nuclear factors that bind to constitutive and inducible enhancers. J Neoroimmunol 41: 35-42.
46. Massa PT, Ozato K, McFarlin DE (1993). Cell type-specific regulation of major histocompatibility complex (MHC) class I gene expression in astrocytes, oligodendrocytes, and neurons. Glia 8: 201-207.
47. Massa PT, Wu H (1995). Interferon regulatory factor element and Interferon regulatory factor 1 in the induction of major histocompatibility complex class I genes in neural cells. J Interferon and Cytokine Res 15: 799-810.
48. McCutchan JH, Pagano JG (1968). Enhancement of the infectivity of simian virus 40 deoxyribonucleic acid with diethylamino-ethyl-dextran. J Natl Cancer Inst 41: 351-356.
49. Meier E and Schousboe A (1982). Differences between GABA receptor binding to membranes from cerebellum during postnatal development and from cultured cerebellar granule cells. Dev Neurosci 5: 546-553.
50. Miyazaki J-I, Appella E, Ozato K (1986). Negative regulation of the major histocompatibility class I gene in undifferentiated embryonal carcinoma cells. Proc Natl Acad Sci USA 83: 9537-9541.
51. Mokhtarian F, Wesselingh SL, Choi S, Maeda A, Griffin DE, Sobel RA (1996). Production and role of cytokines in the CNS of mice with acute viral encephalomyelitis. J Neuroimmunol 66: 11-22.
52. Mucke L, Oldstone MB (1992). The expression of major histocompatibility complex (MHC) class I antigens in the brain differs markedly in acute and persistent infections with lymphocytic choriomeningitis virus (LCMV). J Neuroimmunol 36: 193-198.
53. Oldstone MBA, Blount P, Southern PJ, Lampert PW (1986). Cytoimmunotherapy for persistent virus infection reveals a unique clearance pattern from the central nervous system. Nature 321: 239-243.
54. Oldstone MBA (1997). How viruses escape from cytotoxic T lymphocytes - molecular parameters and players. Virol 234: 179-185.
55. Rail GF, Mucke L, Oldstone MBA (1995). Consequences of cytotoxic T lymphocyte interactions with major histocompatibility complex class I-expressing neurons in vivo. J Exp. Med 182: 1201-1212.
56. Reed LJ, Muench M (1983). A simple method for estimating fifty percent endpoints. Amer J Hyg 27: 493-497.
57. Reich NC, Darnell Jr JE (1989). Differential binding of interferon-induced factors to an oligoncuelotide that mediates transcriptional activation. Nucleic Acids Res 17: 3415-3424.
58. Rutherford MN, Hannigan GE, Williams BR (1988). Interferon-induced binding of nuclear factors to promoter elements of the 2-5A synthetase gene. EMBO J 7: 751-759.
59. Rutherford MN, Kumar A, Nissim A, Chebath J, Williams BR (1991). The murine 2-5A synthetase locus: three distinct transcripts from two linked genes. Nucleic Acids Res 19: 1917-1924.
60. Rutherford MN, Kumar A, Coulombe B, Skup D, Carver DH, Williams BRG (1996). Expression of intracellular Interferon constitutively activates ISGF3 and confers resistance to EMC viral infection. J Interferon and Cytokine Res. 16: 507-510.
61. Saunders ME, Gewert DR, Tugwell ME, McMahon M, Williams BRF (1985). Human 2-5A synthetase: characterization of a novel cDNA and corresponding gene structure. EMBO J 4: 1761-1768.
62. Schijns VE, Van der Neut R, Haagmans BL, Bar DR, Schellekens H, Horzinek MC (1991). Tumor necrosis factor-alpha, interferon-gamma and interferon-beta exert antiviral activity in nervous tissue cells. J Gen Virol 72: 809-815.
63. Sedgwick JD, Dorries R (1991). The immune system response to viral infection of the CNS. Sem Neurosci 3: 93-100.
64. Segars JH, Nagata T, Bours V, Medin JA, Franzoso G, Blanco JC, Drew PD, Becker KG, An J, Tang T, Stephany DA, Neel B, Siebenlist U, Ozato K (1993). Retinoic acid induction of major histocompatibility complex class I genes in NTera-2 embryonal carcinoma cells involves induction of NF-κB (p50-p65) and retinoic acid receptor-beta-retinoid X receptor beta heterodimers. Mol Cell Biol 13: 6157-6169.
65. Sen GC, Ransohoff RM (1993). Interferon-induced antiviral actions and their regulation. Adv Virus Res 42: 57-102.
66. Sriram S, Topham DJ, Huang SK, Rodriguez M (1989). Treatment of encephalomyocarditis virus-induced central nervous system demyelination with monoclonal anti-T-cell antibodies. J Virol 63: 4242-4248.
67. Steinhoff U, Muller U, Schertler A, Hengartner H, Aguet M and Zinkernagel RM (1995). Antiviral protection by vesicular stomatitus virus-specific antibodies in alpha/ beta interferon receptor-deficient mice. J Virol 69: 2153-2158.
68. Tanaka N, Kawakami T, Taniguchi T (1993). Recognition DNA sequences of interferon regulatory factor 1 (IRF-1) and IRF-2, regulators of cell growth and the interferon system. Mol Cell Biol 13: 4531-4538.
69. Tucker PC, Griffin DE, Choi S, Bui N, Wesselingh S (1996). Inhibition of nitric oxide synthesis increases mortality in sindbis virus encephalitis. J Virol 70: 3972-3977.
70. γ that mediate protein-DNA and protein-protein interactions during transcription factor assembly contribute to DNA-binding specificity. Mol Cell Biol 13: 196-206.
71. Ward LA, Massa PT (1995). Neuron-specific regulation of major histocompatibility complex class I, interferon-β, and anti-viral state genes. J Neuroimmunol 58: 145-155.
72. Williams BRG, Golgher RR, Brown RE, Gilbert CS, Kerr IM (1979). Natural occurrence of 2-5A in interferon-treated EMC virus-infected L colls. Nature 282: 582-586.
73. Yamamoto H, Lamphier MS, Fujita T, Taniguchi T, Harada H (1994). The oncogenic transcription factor IRF-2 possesses a transcriptional repression and a latent activation domain. Oncogene 9: 1423-2428.